FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Hans

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
William W L Choi; Dennis D Weisenburger; Timothy C Greiner; Miguel A Piris; Alison H Banham; Jan Delabie; Rita M Braziel; Huimin Geng; Javeed Iqbal; Georg Lenz; Julie M Vose; Christine P Hans; Kai Fu; Lynette M Smith; Min Li; Zhongfeng Liu; Randy D Gascoyne; Andreas Rosenwald; German Ott; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; David L Jaye; Louis M Staudt; Wing C Chan
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
Kai Fu; Dennis D Weisenburger; William W L Choi; Kyle D Perry; Lynette M Smith; Xinlan Shi; Christine P Hans; Timothy C Greiner; Philip J Bierman; R Gregory Bociek; James O Armitage; Wing C Chan; Julie M Vose
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Yasodha Natkunam; Pedro Farinha; Eric D Hsi; Christine P Hans; Robert Tibshirani; Laurie H Sehn; Joseph Michael Connors; dita gratzinger; Manuel Rosado; Shuchun Zhao; Brad Pohlman; Nicholas Wongchaowart; Martin Bast; Abraham Avigdor; Ginette Schiby; Arnon Nagler; Gerald E Byrne; Ronald Levy; Randy D Gascoyne; Izidore S Lossos
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Hans (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: William W L Choi; Dennis D Weisenburger; Timothy C Greiner; Miguel A Piris; Alison H Banham; Jan Delabie; Rita M Braziel; Huimin Geng; Javeed Iqbal; Georg Lenz; Julie M Vose; Christine P Hans; Kai Fu; Lynette M Smith; Min Li; Zhongfeng Liu; Randy D Gascoyne; Andreas Rosenwald; German Ott; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; David L Jaye; Louis M Staudt; Wing C Chan
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5494-502.
2008: Kai Fu; Dennis D Weisenburger; William W L Choi; Kyle D Perry; Lynette M Smith; Xinlan Shi; Christine P Hans; Timothy C Greiner; Philip J Bierman; R Gregory Bociek; James O Armitage; Wing C Chan; Julie M Vose
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4587-94.
2008: Yasodha Natkunam; Pedro Farinha; Eric D Hsi; Christine P Hans; Robert Tibshirani; Laurie H Sehn; Joseph Michael Connors; dita gratzinger; Manuel Rosado; Shuchun Zhao; Brad Pohlman; Nicholas Wongchaowart; Martin Bast; Abraham Avigdor; Ginette Schiby; Arnon Nagler; Gerald E Byrne; Ronald Levy; Randy D Gascoyne; Izidore S Lossos
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):447-54.
2008: Shane K Kohl; Christine P Hans
Cutaneous malakoplakia.
Archives of pathology & laboratory medicine 2008;132(1):113-7.
2007: Javeed Iqbal; Timothy C Greiner; K Patel; Bhavana J Dave; L Smith; J Ji; George Wright; Warren G Sanger; Diane L Pickering; S Jain; Douglas E Horsman; Y Shen; Kai Fu; Dennis D Weisenburger; Christine P Hans; Elias Campo; Randy D Gascoyne; Andreas Rosenwald; Elaine S Jaffe; Jan Delabie; Lisa M Rimsza; German Ott; Hans Konrad Müller-Hermelink; Joseph Michael Connors; Julie M Vose; Timothy W McKeithan; Louis M Staudt; Wing C Chan
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
Leukemia 2007;21(11):2332-43.
2006: Apar Kishor Ganti; Dennis D Weisenburger; Lynette M Smith; Christine P Hans; R Gregory Bociek; Philip J Bierman; Julie M Vose; James O Armitage
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):920-7.
2006: Javeed Iqbal; Vishala T Neppalli; George Wright; Bhavana J Dave; Douglas E Horsman; Andreas Rosenwald; James Lynch; Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Elias Campo; German Ott; Hans Konrad Müller-Hermelink; Jan Delabie; Elaine S Jaffe; Thomas M Grogan; Joseph Michael Connors; Julie M Vose; James O Armitage; Louis M Staudt; Wing C Chan
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):961-8.
2005: Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Wing C Chan; Patricia Aoun; Gregory T Cochran; Zenggang Pan; Lynette M Smith; James C Lynch; R Gregory Bociek; Philip J Bierman; Julie M Vose; James O Armitage
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1377-84.
2005: Youli Zu; Seth M Steinberg; Elias Campo; Christine P Hans; Dennis D Weisenburger; Rita M Braziel; Jan Delabie; Randy D Gascoyne; Konrad Muller-Hermlink; Stefania Pittaluga; Mark Raffeld; Wing C Chan; Elaine S Jaffe
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.
Leukemia & lymphoma 2005;46(5):693-701.
2004: Javeed Iqbal; Warren G Sanger; Douglas E Horsman; Andreas Rosenwald; Diane L Pickering; Bhavana J Dave; Sandeep Dave; Li Xiao; Kajia Cao; Quiming Zhu; Simon Sherman; Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; German Ott; Hans Konrad Müller-Hermelink; Jan Delabie; Rita M Braziel; Elaine S Jaffe; Elias Campo; James C Lynch; Joseph Michael Connors; Julie M Vose; James O Armitage; Thomas M Grogan; Louis M Staudt; Wing C Chan
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
The American journal of pathology 2004;165(1):159-66.
2004: Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; Hans Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph Michael Connors; James O Armitage; Wing C Chan
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Blood 2004;103(1):275-82.
2003: Wing C Chan; Christine P Hans
Genetic and molecular genetic studies in the diagnosis of T and NK cell neoplasia.
Human pathology 2003;34(4):314-21.
2003: Christine P Hans; Dennis D Weisenburger; Julie M Vose; Lynette M Hock; James C Lynch; Patricia Aoun; Timothy C Greiner; Wing C Chan; R Gregory Bociek; Philip J Bierman; James O Armitage
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Blood 2003;101(6):2363-7.